BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210518
DTEND;VALUE=DATE:20210521
DTSTAMP:20260515T181353
CREATED:20210211T103519Z
LAST-MODIFIED:20210211T103816Z
UID:28913-1621296000-1621555199@www.pharmajournalist.com
SUMMARY:Genetic Vaccine Development for Infectious Diseases Summit
DESCRIPTION:The COVID-19 pandemic brought life-changing disruptions to people around the world and has turned the typical vaccine R&D process on its head. A combination of urgent need\, unprecedented investments\, and advances in genetic engineering has allowed what was once mere speculation to become not only our reality\, but our future. \n \nWith pandemic vaccines now launching at record speeds\, the first Genetic Vaccine Development for Infectious Diseases Summit will focus on overcoming the translational and clinical challenges of developing genetic vaccines targeting infectious diseases\, including Influenza\, Lassa fever\, Ebola\, MERS\, HIV\, Zika\, and COVID-19. \nWith a focus on mRNA\, DNA\, and engineered viral vector-based vaccines\, this niche 3-day agenda has been specifically designed to help industry experts to discuss new genetic-based vaccine platforms\, preclinical and clinical case studies\, optimized delivery methods\, and the future of vaccine R&D to usher in a new era of vaccinology\, with experts from BioNTech\, Pfizer\, Moderna\, AstraZeneca and CureVac. \nTo know more about Genetic Vaccine Development for Infectious Diseases Summit please\nclick here.
URL:https://www.pharmajournalist.com/event/genetic-vaccine-development-for-infectious-diseases-summit/
LOCATION:Online
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210520
DTEND;VALUE=DATE:20210522
DTSTAMP:20260515T181353
CREATED:20210226T102847Z
LAST-MODIFIED:20210226T102847Z
UID:29162-1621468800-1621641599@www.pharmajournalist.com
SUMMARY:5th Annual MarketsandMarkets Bioprocessing of Biotherapeutics-UK\,EU & APAC-Virtual
DESCRIPTION:After the successful four editions of Bioprocessing of Cell therapies\, coming up with 5th Annual of Bioprocessing of Biotherapeutics brings together leading bioprocessing scientists to share day-to-day challenges and practical solutions for the development\, manufacture and quality of protein expressions\, cell\, and gene therapies. \nThe virtual event will present detailed case studies and interactive discussions in cell culture\, scale-up\, continuous processing\, recovery\, purification\, process and product characterization\, and formulation. \nEvent Website: https://events.marketsandmarkets.com/5th-annual-marketsandmarkets-bioprocessing-of-biotherapeutics-uk-eu-apac-virtual/ \nRegistration link:  https://events.marketsandmarkets.com/5th-annual-marketsandmarkets-bioprocessing-of-biotherapeutics-uk-eu-apac-virtual/register 
URL:https://www.pharmajournalist.com/event/5th-annual-marketsandmarkets-bioprocessing-of-biotherapeutics-ukeu-apac-virtual/
LOCATION:Virtual Event
ORGANIZER;CN="Marketsandmarkets":MAILTO:Shardul.oza@marketsandmarkets.com, events@marketsandmarkets.com
END:VEVENT
END:VCALENDAR